Carcell Biopharma

Recent Finacing

Pre-Series A

Recent Raise

Undisclosed

Carcell Biopharma develops engineered red blood cell immunomodulation and LNP non-viral gene-delivery platforms, operating R&D in Singapore with Shanghai manufacturing and planned Boston clinical site to advance IND-enabling studies.